Nocera Files S-1/A for 45M Share Resale, Eyes US Aquaculture Expansion

TL;DR

**NCRA's S-1/A is a red flag for dilution, as a massive share resale at a deep discount could hammer the stock, despite their ambitious aquaculture expansion plans.**

AI Summary

Nocera, Inc. (NCRA) is offering 45,000,000 shares of common stock for resale by a selling stockholder, convertible from 13,500 shares of Series B Convertible Non-Voting Preferred Stock. The assumed conversion price is $0.30 per share, significantly below the December 8, 2025 Nasdaq closing price of $0.8791 per share. Nocera, incorporated in Nevada in 2002, designs and produces large-scale recirculating aquaculture systems (RASs) and provides consulting services for fish farms, with operations based in New Taipei City, Taiwan. The company ceased all China operations in October 2020 to focus on Taiwan's Green Power and Solar Sharing Fish Farms initiative. Key strategic moves include the acquisition of an 80% controlling interest in Meixin Institutional Food Development Co., Ltd. for $4,300,000 in September 2022 and the establishment of Xin-Feng Construction Co. Ltd. (a VIE) in December 2020 to obtain a Class A construction license in Taiwan. Nocera plans to expand into the U.S. market and has invested over $2 million in business operations to date. The company will not receive any proceeds from this specific offering, which is solely for the selling stockholder.

Why It Matters

This S-1/A filing signals a significant potential dilution event for existing NCRA shareholders, as 45,000,000 shares are being registered for resale at an assumed conversion price of $0.30, well below the current market price of $0.8791. For investors, this means a large block of shares could enter the market, potentially impacting stock price stability. Employees and customers might see this as a step towards broader market presence, especially with Nocera's stated intent to expand into the U.S. and become a global leader in land-based aquaculture. In the competitive aquaculture sector, Nocera's focus on RAS technology and solar-sharing fish farms positions it uniquely, but the success of its expansion strategy, particularly in the U.S., will be critical for long-term growth and market impact.

Risk Assessment

Risk Level: high — The offering involves the potential resale of 45,000,000 shares of common stock by a selling stockholder, convertible from Series B Preferred Stock at an assumed floor price of $0.30 per share. This is significantly lower than the December 8, 2025 closing price of $0.8791, indicating substantial potential dilution for existing shareholders if these shares are converted and sold. The company also explicitly states, "Investing in our securities involves a high degree of risk" on page 8.

Analyst Insight

Investors should exercise extreme caution and thoroughly evaluate the potential for significant dilution from the 45,000,000 shares being registered for resale. Consider the impact of a large block of shares entering the market at a price substantially below current trading levels before making any investment decisions in NCRA.

Key Numbers

• 45,000,000 — Shares of Common Stock (Being offered for resale by the Selling Stockholder)
• $0.30 — Assumed Conversion Price (Floor price for Series B Preferred Stock conversion to common stock)
• $0.8791 — Last Reported Sale Price (NCRA common stock on Nasdaq as of December 8, 2025)
• 13,500 — Shares of Series B Preferred Stock (Convertible into common stock for resale)
• $4,300,000 — Acquisition Cost (For 80% controlling interest in Meixin Institutional Food Development Co., Ltd.)
• $2,000,000 — Investment in Business Operations (Amount invested by Company and management to date)
• 2002 — Incorporation Year (Nocera, Inc. was incorporated in Nevada)
• 2020 — Year of China Exit (Nocera ceased all operations in China in October 2020)

Key Players & Entities

• Nocera, Inc. (company) — Registrant and aquaculture system provider
• The Nasdaq Capital Market (regulator) — Stock exchange where NCRA is listed
• Securities and Exchange Commission (regulator) — Regulatory body for the S-1/A filing
• Ross D. Carmel, Esq. (person) — Agent for service from Sichenzia Ross Ference Carmel LLP
• Sichenzia Ross Ference Carmel LLP (company) — Legal counsel for Nocera, Inc.
• Meixin Institutional Food Development Co., Ltd. (company) — Taiwan corporation, 80% controlling interest acquired by Nocera
• Xin-Feng Construction Co. Ltd. (company) — Variable Interest Entity (VIE) for construction license in Taiwan
• Taiwan (regulator) — Primary operational base and market focus for Nocera
• United States (regulator) — Target market for Nocera's expansion
• China (regulator) — Former primary market for Nocera, operations ceased in October 2020

FAQ

Risk Factors

• Dependence on Key Personnel and Management [high — operational]: The company's success is heavily reliant on its key management personnel, particularly its CEO, Mr. Chi-Feng Lin. The departure of any key executive could materially and adversely affect the company's operations, financial condition, and prospects. There is no assurance that the company can retain its key employees or attract and retain qualified management in the future.
• Limited Operating History and Profitability Concerns [high — financial]: Nocera, Inc. has a limited operating history and has not yet achieved profitability. The company has incurred net losses in prior periods and expects to continue to incur operating losses for the foreseeable future as it invests in expanding its business. This lack of a proven track record and ongoing losses pose significant financial risks.
• Foreign Operations and Regulatory Compliance [medium — regulatory]: The company's operations in Taiwan are subject to various Taiwanese laws and regulations. Changes in these regulations, or the company's failure to comply with them, could result in fines, penalties, or suspension of operations. The use of a VIE structure for Xin-Feng Construction Co. Ltd. also introduces specific regulatory risks associated with such arrangements in China and potentially other jurisdictions.
• Competition in the Aquaculture and Construction Industries [medium — market]: Nocera operates in competitive markets, including large-scale recirculating aquaculture systems (RASs) and construction. The company faces competition from established players and new entrants. Failure to differentiate its products and services or maintain competitive pricing could negatively impact market share and profitability.
• Reliance on Selling Stockholder for Offering Proceeds [low — financial]: This offering involves the resale of shares by a selling stockholder, and Nocera, Inc. will not receive any proceeds from the sale of these 45,000,000 shares. This means the company will not benefit financially from this transaction to fund its growth or operations, relying instead on its own capital raising efforts or operational cash flow.
• Geographic Concentration of Operations [medium — operational]: The company's primary operations are concentrated in Taiwan following the cessation of China operations in October 2020. This geographic concentration exposes Nocera to risks associated with political instability, economic downturns, natural disasters, or regulatory changes specific to Taiwan.
• Potential Dilution from Preferred Stock Conversion [high — financial]: The 13,500 shares of Series B Convertible Non-Voting Preferred Stock are convertible into 45,000,000 shares of common stock at an assumed conversion price of $0.30 per share. If this conversion occurs, it will significantly dilute existing common stockholders' ownership percentage and could impact the market price of the common stock.

Industry Context

Nocera operates within the growing aquaculture technology sector, focusing on large-scale recirculating aquaculture systems (RASs) to promote sustainable fish farming. The company also has a presence in the construction sector in Taiwan. The RAS market is driven by increasing demand for seafood, environmental concerns, and technological advancements in water treatment and fish health management.

Regulatory Implications

Nocera's operations in Taiwan are subject to local environmental, construction, and business regulations. The use of VIE structures for its construction arm introduces potential complexities and scrutiny regarding foreign ownership rules and contractual control. Compliance with these diverse regulatory frameworks is critical for sustained operations.

What Investors Should Do

1. Evaluate the dilution impact of the Series B Preferred Stock conversion.
2. Analyze the company's path to profitability and cash flow generation.
3. Assess the risks associated with foreign operations and VIE structures.
4. Understand the strategic rationale behind the Meixin acquisition.

Key Dates

• 2002-01-01: Company Incorporation — Marks the establishment of Nocera, Inc. as a legal entity in Nevada.
• 2020-10-01: Cessation of China Operations — Strategic decision to exit the Chinese market and focus resources on Taiwan's Green Power and Solar Sharing Fish Farms initiative.
• 2020-12-01: Establishment of Xin-Feng Construction Co. Ltd. (VIE) — Created to obtain a Class A construction license in Taiwan, indicating expansion into construction services.
• 2022-09-01: Acquisition of Meixin Institutional Food Development Co., Ltd. — Acquired an 80% controlling interest for $4,300,000, signifying a strategic move to integrate food development operations.
• 2025-12-08: Nasdaq Closing Price — Reported closing price of $0.8791 for NCRA common stock, providing a market valuation reference point.

Glossary

Recirculating Aquaculture Systems (RASs)

Advanced farming systems that treat and recirculate water, minimizing water usage and environmental impact for fish farming. (Core technology and product offering of Nocera, Inc.)

Series B Convertible Non-Voting Preferred Stock

A class of preferred stock that can be converted into common stock but does not carry voting rights. (The instrument from which the 45,000,000 shares offered for resale are derived.)

Selling Stockholder

An existing shareholder who is offering their shares for sale to the public, as opposed to the company itself selling newly issued shares. (This offering is solely for the benefit of the selling stockholder; Nocera, Inc. receives no proceeds.)

Variable Interest Entity (VIE)

A legal structure used to consolidate entities that are not technically owned but are controlled through contractual agreements, often used to circumvent foreign ownership restrictions. (Xin-Feng Construction Co. Ltd. is structured as a VIE, introducing specific regulatory and control risks.)

Assumed Conversion Price

The price at which preferred stock is converted into common stock, used here as a floor price for the resale offering. (Set at $0.30 per share, significantly below the current market price, indicating potential for substantial dilution.)

Year-Over-Year Comparison

Information regarding previous filings and comparative financial metrics is not available in the provided context. Therefore, a comparison of key metrics such as revenue growth, margin changes, and new risks versus a prior filing cannot be performed.

Key Financial Figures

• $0.001 — 0,000 shares of common stock, par value $0.001 per share (the "common stock"), of Noce
• $0.30 — rice of the Series B Preferred Stock is $0.30 per share of common stock, which is the
• $0.8791 — stock on The Nasdaq Capital Market was $0.8791 per share. We are an "emerging growth
• $4,300,000 — 80% controlling interest of Meixin for $4,300,000. The Meixin VIE Agreements essentially
• $2 million — its management have invested more than $2 million in the development of the Company's bus
• $17.01 million — and 2023, net sales were approximately $17.01 million and approximately $23.9 million, respec
• $23.9 m — mately $17.01 million and approximately $23.9 million, respectively. Suppliers We in
• $1.235 billion — we have total annual gross revenues of $1.235 billion or more; (iii) the date on which we hav
• $1 billion — date on which we have issued more than $1 billion in nonconvertible debt during the previ

Filing Documents

• nocera_s1a1.htm (S-1/A) — 368KB
• nocera_ex2301.htm (EX-23.1) — 2KB
• logo.jpg (GRAPHIC) — 4KB
• image_001.jpg (GRAPHIC) — 25KB
• image_004.jpg (GRAPHIC) — 3KB
• 0001683168-25-009111.txt ( ) — 942KB
• ncra-20250930.xsd (EX-101.SCH) — 3KB
• ncra-20250930_cal.xml (EX-101.CAL) — 69KB
• ncra-20250930_def.xml (EX-101.DEF) — 29KB
• ncra-20250930_lab.xml (EX-101.LAB) — 82KB
• ncra-20250930_pre.xml (EX-101.PRE) — 62KB
• nocera_s1a1_htm.xml (XML) — 4KB

Use of Proceeds

Use of Proceeds 24

DESCRIPTION OF SECURITIES

DESCRIPTION OF SECURITIES 25 August 2025 Private Placement 29 Selling Stockholder 30 Plan of Distribution 31 Legal Matters 32 Experts 32 incorporation of certain information by reference 32 Where You Can Find More Information 33 i ABOUT THIS PROSPECTUS This prospectus describes the general manner in which the Selling Stockholder may offer from time to time the Conversion Shares. You should rely only on the information contained in or incorporated by reference into this prospectus and the related exhibits, any prospectus supplement or amendment thereto and the documents to which we have referred you, before making your investment decision. Neither we nor the Selling Stockholder have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. This prospectus, any prospectus supplement or amendments thereto do not constitute an offer to sell, or a solicitation of an offer to purchase, the common stock offered by this prospectus, any prospectus supplement or amendments thereto in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in such jurisdiction. You should not assume that the information contained in this prospectus, any prospectus supplement or amendments thereto, as well as information we have previously filed with the SEC, is accurate as of any date other than the date on the front cover of the applicable document. If necessary, the specific manner in which the shares of common stock may be offered and sold will be described in a supplement to this prospectus, which supplement may also add, update or change any of the information contained in this prospectus. To the extent there is a conflict between the information contained in this prospectus and any prospectus supplement, you should rely on the information in such prospectus supplement, provided that if any s

View Full Filing

View this S-1/A filing on SEC EDGAR